ArticleFrontiers in pharmacology2022

Cost-effectiveness analysis of adebrelimab combined with chemotherapy for extensive-stage small cell lung cancer.

Maojin You et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.